Novavax stock soars over 20% after COVID-19 vaccine study shows nearly 90% efficacy in UK, but less against new South African variant – MarketWatch

Novavax stock soars over 20% after COVID-19 vaccine study shows nearly 90% efficacy in UK, but less against new South African variant – MarketWatch

Shares of Novavax Inc. jumped more than 20% in after-hours trading on Thursday, after the company revealed the results of studies that showed its proposed COVID-19 vaccine to be globally effective at nearly 90%, but much less effective against a new variant. In a phase 3 trial in the UK, Novavax NVAX, + 64.87% the […]
The post Novavax stock soars over 20% after COVID-19 vaccine study shows nearly…

View On WordPress